Home
>
National Drug Code (NDC)
>
Cladribine
Cladribine - 47351-017-10 - (Cladribine)
Drug Information of Cladribine
| Product NDC: | 47351-017 |
| Proprietary Name: | Cladribine |
| Non Proprietary Name: | Cladribine |
| Active Ingredient(s): | 1 mg/mL & nbsp; Cladribine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cladribine
| Product NDC: | 47351-017 |
| Labeler Name: | Onco Therapies Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200510 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111007 |
Package Information of Cladribine
| Package NDC: | 47351-017-10 |
| Package Description: | 10 mL in 1 VIAL (47351-017-10) |
NDC Information of Cladribine
| NDC Code | 47351-017-10 |
| Proprietary Name | Cladribine |
| Package Description | 10 mL in 1 VIAL (47351-017-10) |
| Product NDC | 47351-017 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cladribine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20111007 |
| Marketing Category Name | ANDA |
| Labeler Name | Onco Therapies Limited |
| Substance Name | CLADRIBINE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Purine Antimetabolite [EPC] |
